Dear Colleagues,

We are honored to invite you to the single topic conference on non responders that will be held in Istanbul on 13 to 15 October 2016. Such problems as the exposure of patients to cirrhosis of the liver, and its complications due to the unresponsiveness of chronic hepatitis B, C, and delta infections, to the current treatments; the development of hepatocellular carcinoma; and recurrence of infections following liver transplantation continue to be challenging issues in today’s world. New research with respect to patients with chronic hepatitis and who do not respond, specifically to the treatments specified in the treatment guidelines, will be presented, and interactive discussions will be held with the world’s opinion leaders on hepatology.

At the same time, the similarities and differences (if any) in terms of treatment between the East and the West will be debated. In particular, the steadily increasing trends in cirrhosis of the liver and hepatocellular cancer rates dependent on the unresponsiveness of the hepatitis C virus, between 2020-2030, will be confronted. For this reason, the treatment of compensated and/or decompensated cirrhosis of the liver being unresponsive or partially responsive to previous treatments or those developing dependent on relapses following treatment will continue to be a globally significant health problem.

Following the discovery of the Neolithic settlement during excavations in Yenikapı (the ancient port of Theodosius) it is now understood that the origins of Istanbul date back at least 8,500 years. The city of Istanbul was known as Byzantium by the Greeks in 700 BCE; as Constantinople it was the capital of the Roman and Eastern Roman Empires. Following the conquest of the city by the Ottoman Empire in 1453, the city remained the capital of the Ottoman Empire for almost five centuries, and was known to the Turks as Istanbul.

Among the most important monuments defining the culture and identity of the city are, the Hippodrome, the Basilica Cistern and the Column of Constantine date, which date from Roman times. Then there is the Galata Tower but by the Genoese, and of course, Haghia Sophia, which still stands as the most important testament to the Byzantine age in the world after 1500 years. Then there are the Ottoman buildings, such as the Topkapı Palace, for centuries the residence of the Ottoman sultans and the administrative center, together with more than 80 museums and 9 other Ottoman palaces. The Sultanahmet Mosque and Süleymaniye Mosque and superb examples of Ottoman religious architecture and the Grand Bazaar and Spice Market (Kapalıçarşı and Mısır Çarşısı), both still going strong today, continue the commercial tradition, for which Istanbul is so famous.

Istanbul’s cultural heritage has given the city international importance: in 2010 it was the European Capital of Culture and it is now included in the UNESCO World Heritage List. With its historical and natural beauties, bridges and underwater tunnel connecting the Asian and European continents, Istanbul shines like pearl on the Bosphorus.

Its ancient history and five centuries as the capital of the Ottoman Empire mean that alongside its own cultural wealth and culinary diversity, Istanbul embraces the illustrious cuisines of Asia, Europe and Africa. Turkish cuisine, now only second to Chinese in terms of popularity, celebrates its huge range of dishes, amazingly there are more than 400 varieties of dessert alone, and all of them are distinctive and delicious.

We would like to conclude by saying how We will be more than pleased to be your host in Istanbul, offering you the finest Traditional Ottoman Hospitality on the occasion of this scientifically rich program.

Kind regards,

Prof Dr Abdul Kadir Dokmeci
Honorary President of
APASL Single Topic Conference 2018 Istanbul

Prof Dr Necati Örmeci
President of
APASL Single Topic Conference 2018 Istanbul

APASL 2018 Annual Meeting in New Delhi
Abstract Submission is Now Open!

Invitation

Dear Colleagues,

It is a great pleasure for us to invite you to the 27th Asian Pacific Association for the Study of the Liver (APASL 2018) that will be held from March 14 to 18, 2018 in New Delhi, India.. We are delighted to welcome you to the cultural and historical metropolis of New Delhi. The conference program will have high quality content with up-to-date information by eminent researchers and clinicians, covering all aspects of Hepatology. The conference will provide an avenue for cooperation and collaboration amongst various institutions, academicia, companies, associations, non-profit organizations, and other related sectors, to deliver benefits to the people in the Asian Pacific region, where liver disease continues to be a major problem area. This would be the perfect opportunity for all of us to share our views, values, experiences and practices regarding liver diseases, such as Viral Hepatitis, Liver Cancers, NASH, Liver Failure, Portal hypertension, Alcoholic Liver Disease, Liver Transplantation, Pediatric Liver Diseases, Liver Radiology, and other topics. We are looking forward to welcome you to New Delhi. With warmest regards,

Dr. Shiv K Sarin Honorary President

Dr. B C Sharma President

Dr. Manoj K Sharma Organizing Secretary

---

APASL 2018 Organizing Committee

Shiv K Sarin President

Barjesh C Sharma Honorary President

Manoj K Sharma Organizing Secretary

Rakhi Maiwall Treasurer

Yogesh Chawla Scientific Committee Chairman

For more information, please visit APASL 2018 New Delhi Website at
http://www.apasl2018.in

Online Registration: http://in.eregnow.com/ticketing/register/apasl2018

Facebook: https://www.facebook.com/apasl2018

Twitter: https://twitter.com/apasl2018

It is a great pleasure to announce you that APASL will start to call for application of APASL New Awards: Rising Star Award and Named Award which will start to be included in the scientific program from APASL2018 in New Delhi.

APASL New Awards is still available.

An application form can be downloaded by clicking here: http://www.apasl.info/applicationform-award.docx Please fill in and send to the APASL secretariat (apasl_secretariat@apasl.info). We are looking forward to receiving your application.

Abstract Submission and Pre-Registration now open!

Dear colleagues,

On behalf of the Organizing Committee, it gives us great pleasure to invite you to Asian Pacific Association for the Study of the Liver Single Topic Conference (APASL STC), which will be held on May 11-13, 2018 in Yokohama, Japan. We are delighted to welcome you to the beautiful, international city.

Under the theme of “HCC: Strategy in the New Era”, the conference program will present high-quality content based on up-to-date information and cutting edge lectures by eminent researchers, in order to reconfirm the achievement of better basic and clinical practice in the field of hepatocellular carcinoma (HCC).

The scientific program will consist of invited lectures, plenary sessions, symposia, and free papers on significant developments on the theme of “HCC: Strategy in the New Era”. The program will also provide the latest information and fresh ideas for hepatologists.

The conference encourages the submission of abstracts on research for oral and poster presentations through the conference website: http://www.apaslstc-hcc2018.org/. We would appreciate your submission and anticipate a large number of entries, which will stimulate active discussions. We would accept all categories of abstracts on HCC, including case reports.

Approximately 1000 delegates of experts from all over the world are expected to attend this conference. We are sure that this will provide an excellent opportunity for those of us in the Asian Pacific region to share the latest views, values, experience and practice, and greatly contribute to this field.

We look forward to welcoming you in Yokohama.

With warmest regards,

Shuichiro Shiina, MD, PhD
President, APASL STC 2018 on HCC
Professor, Department of Gastroenterology, Juntendo University

Abstract Submission for Free Paper is now available through online at http://www.apaslstc-hcc2018.org/.
Presentation Style: Poster or Oral Presentation *Excellent papers will be awarded and selected for Oral presentation.

Yokohama, is the first harbor city introduced to the world as the entrance to Japan. Since the time its port was opened, Yokohama has been vigorously acquiring new cultures and information from foreign countries and introducing to Japan our country’s first-time-ever things from food to a wide range of cultures, which entitles Yokohama as the birthplace of Japan’s modern culture. The Yokohama, referred to as “Hamakko” in Japanese, has been very cheerful at enjoying life and willing to adopt whatever is good. Such a tradition of the “Hamakkos” cultivated long ago has been incorporated into the present fashionable and sophisticated streetscape.

---

---

---

---

---

---

---

---

---

---

---

Now the APASL Guidelines have been published in Hepatology International as follows!!!

APASL Guidelines for HBV -"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update" (Hepatol Int 2016; 10:1–98)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl-hbv-guideline-2016.pdf

APASL Guidelines for HCV -”APASL consensus statements and recommendation for hepatitis C prevention, epidemiology, and laboratory testing” (Hepatol Int (2016) 10:681–701)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2017/02/APASL-consensus-statements-and-recommendations-for-hepatitis-C-prevention-epidemiology-and-laboratory-testing.pdf

APASL Guidelines for HCV -”APASL consensus statements and recommendation on treatment of hepatitis C” (Hepatol Int (2016) 10:702–726)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2017/02/APASL-consensus-statements-and-recommendation-on-treatment-of-hepatitis-C.pdf

APASL Guidelines for HCC -”Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update” (Hepatol Int 2017; 11: 317-370)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2017/08/Asia–Pacific-clinical-practice-guidelines-on-the-management-of-hepatocellular-carcinoma-a-2017-update.pdf

APASL Guidelines for Acute-on-chronic Liver Failure -”Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL) 2014” (Hepatol Int 2014; 8: 453-471)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2016/06/Guidelines-for-Acute-on-chronic-Liver-Failure-2014.pdf

APASL Guidelines for Fibrosis -”Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)” (Hepatol Int 2009; 3: 323-333)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2016/06/Guideline-for-Fibrosis.pdf

APASL consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis a 2016 update (Hepatol Int (2017) 11:1–30)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2017/02/APASL-consensus-guidelines-on-invasive-and-non-invasive-assessment-of-hepatic-fibrosis-a-2016-update.pdf

APASL Guidelines for IPH -”Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment” (Hepatol Int 2007; 1: 398-413)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2016/06/Guideline-for-IPH.pdf

APASL Guidelines for Variceal Bleeding -”Primary prophylaxis of gastroesophageal variceal bleeding: consensus recommendations of the Asian Pacific Association for the Study of the Liver” (Hepatol Int 2008; 2: 429-439)

*This APASL Guideline can be downloaded by clicking below.
http://apasl.info/apasl/wp-content/uploads/2016/06/Guideline-for-Variceal-Bleeding.pdf

The objective of the fellowship is to foster career development by encouraging the beneficial experience of working in a different clinical or research environment in another country in the Asia-Pacific region. These fellowships provide for advanced training in health and medical research in any country in the Asia-Pacific region and enable fellows to work in a clinical environment or on a research project with nominated advisers. We appreciate your generous contributions and support for these APASL fellowships and look forward to a number of high-quality applications for a 2017 fellowship.

An application form can be downloaded by clicking here: http://www.apasl.info/applicationform-fellowship.docx Please fill in and send to the APASL secretariat (apasl_secretariat@apasl.info). We are looking forward to receiving your application. There are no restrictions based on nationality. The sponsoring institution with the academic environment to provide adequate support for the proposed project might be suggested by APASL. Application will be reviewed by APASL Committee members. The decisions of the Committee are final and not subject to appeal.